Cortechs.ai | Cortechs.ai and StatRad partner to help patients with neurodegenerative disease

Cortechs.ai and StatRad partner to help patients with neurodegenerative disease

Strategic relationship between quantitative imaging leader and key teleradiology company provides physicians and hospitals with comprehensive volumetric MRI reports.

(SAN DIEGO) April 8, 2014 – Cortechs.ai, Inc. is pleased to announce a partnership agreement with StatRad, LLC, a leading provider of innovative teleradiology services, which will distribute NeuroQuant® to its hospital and clinic clients. RadConnect, a division of StatRad that provides a medical image sharing platform, will also incorporate NeuroQuant into its solution.

NeuroQuant is the only FDA-cleared medical device for automatic labeling, visualization and volumetric quantification of segmentable brain structures from a set of magnetic resonance images.

“I look forward to providing our clients with NeuroQuant reports,” said Vishal Verma, MD, CEO of StatRad. “We are happy to be able to provide our customers’ referring physicians with quantitative brain volume information that they can use in their assessment of neurodegenerative disease – like Alzheimer’s, Epilepsy, and TBI.  Integration of NeuroQuant into StatRad will provide more streamlined capabilities for our clients.”

StatRad and RadConnect support hospital and clinic clients across the U.S. using FDA-cleared technology to read hundreds of thousands of exams. NeuroQuant reports will be made available to hospital radiologists and referring physicians for specific Brain MRI exams.

“We are pleased to partner with StatRad, an innovative and quality-driven company,” said Guri Stark, CEO of Cortechs.ai. “Working with StatRad and its clients will help us fulfill our mission to assist physicians in effectively diagnosing and treating serious neurological disorders.”

To learn more about CorTechs and NeuroQuant, please visit cortechs.ai.

To learn more about StatRad and RadConnect, please visit www.statrad.com and www.radconnect.com.

About Cortechs.ai, Inc.

CorTechs develops and markets cutting-edge brain imaging solutions used by neurologists and radiologists in hundreds of clinics and research centers around the world.  CorTechs’ flagship product, NeuroQuant®, is a breakthrough, 510(k) cleared medical device that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice.  As the only FDA cleared medical device capable of automatically detecting and quantifying atrophy in the human brain, NeuroQuant® brings sophisticated, accurate, and fully automated MRI post-processing capabilities to the physician’s desktop or mobile device. This provides neurologists, radiologists, and clinical researchers with a convenient and cost-effective means to quantify atrophy of brain structures to help diagnose a variety of brain disorders, including conditions such as Alzheimer’s disease, epilepsy and traumatic brain injury.

About StatRad, LLC

StatRad has been supporting radiology groups through nighttime teleradiology support since 1996. The company’s proprietary internally-developed technology system was specifically built for teleradiology and provides customers with a customizable, user-friendly interface that helps radiology groups streamline processes, increase efficiencies and deliver measurable results. RadConnect, a division of StatRad, provides a medical image sharing platform and vendor neutral archive solution.

###

Media Contact
Contact: Travis Foegler
Phone: +1 (619) 450-9094
Email: Tfoegler@cortechs.ai

More Resources

06/23/2026

Helping Our Clients Share Their Success Stories

Learn how Cortechs helps clients share clinical achievements, workflow improvements, and innovation through case studies, testimonials, webinars, and more.

06/15/2026

Alzheimer’s Awareness Month: Bringing Clarity to the Alzheimer’s Care Continuum Through Quantitative Imaging

Explore how quantitative imaging is helping clinicians assess, diagnose, and monitor Alzheimer’s disease and related dementias with greater clarity.

06/08/2026

Cortechs.ai and TAC Center Celebrate One Year of Advancing Neuroimaging Innovation in Peru

TAC Centers Peru is celebrating one year of integrating the NeuroQuant® suite into clinical practice.

06/04/2026

SNMMI 2026: Advancing the Future of Quantitative PET in Dementia Imaging

At SNMMI 2026, Cortechs.ai showcased NeuroQuant® PET and the growing role of quantitative PET imaging in dementia care.

06/02/2026

Cortechs.ai Collaborates with Microsoft to Bring AI-Powered Imaging Insights Directly into Radiology Workflows

Cortechs.ai and Microsoft are partnering to help bring advanced AI-powered quantitative imaging directly into radiology workflows.

05/26/2026

Cortechs.ai Partners with ARJ Medical to Advance AI-Driven Neuro and Prostate Imaging in the Middle East

Cortechs.ai and ARJ Medical have partnered to expand access to AI-powered neuro and prostate imaging solutions across the Middle East.
Scroll to Top